Basal, commonly known as Triple Negative Breast Cancer (TNBC), is the most aggressive and malignant subtype since it lacks estrogen receptors (ER), progesterone receptors (PR), and does not express the human epidermal growth factor receptor 2 (HER2) (6). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.